H ypertension is a clinical situation associated with endothelial dysfunction and increased vascular reactive oxygen species (ROS) formation. The observations that antioxidants, such as Tempol or apocynin, lower the blood pressure in spontaneously hypertensive rats gave rise to the concept that ROS essentially contribute to hypertension. Recent work, however, has sharpened this view, and it is now clear that the underlying mechanism of ROS-induced hypertension may not be endothelial dysfunction but rather an ROS-dependent modulation of the sympathetic drive, 1 the kidney, and potentially alterations in the immune system. 2 Despite these findings, hypertension has been consistently linked to increased ROS formation in the vascular system. It is, therefore, plausible that ROS are not necessarily the cause but potentially the consequence of hypertension. This notion certainly does not exclude that ROS are involved in the pathogenesis of specific aspects of hypertension, such as the development of fibrosis.
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In keeping with the concept of hypertension-induced ROS formation, it was noted previously that distension of a vessel with an oversized balloon acutely increases ROS formation. 3 Moreover, acute elevation of pressure from 80 to 160 mm Hg enhances the ROS formation and induces an ROS-dependent attenuation of the endothelium-dependent relaxation in isolated rat femoral arteries. 4 Moreover, even in chronic models of isolated hypertension, such as aortic banding, the ROS formation was consistently higher in the hypertensive rather than in the normotensive part.
There is, however, uncertainty regarding the enzymatic sources of ROS, and a contribution of mitochondria, endothelial NO synthase uncoupling, and NADPH oxidases has been suggested. Moreover, little is known about the signaling pathway linking hypertension with ROS formation.
In this issue of Hypertension, Vecchione et al 5 significantly add to our knowledge concerning the latter aspect. With the aid of a wire-myograph system and the isolated murine carotid artery, the authors demonstrate that an increase in vascular stretch, equivalent to a rise in blood pressure from 100 to 180 mm Hg, translocates the integrin-linked kinase 1 (ILK-1) to the plasma membrane, where it interacts with the multidomain adaptor protein paxillin. Small interfering RNA directed against ILK-1 and adenovirus coding for dominantnegative Rac-1 demonstrated that ILK-1 activates Rac-1, which subsequently promotes superoxide anion (O 2 ⅐Ϫ ) formation and endothelial dysfunction. Because NO is a mediator of vascular compliance, it appears possible that endothelial dysfunction further promotes vascular stiffening in hypertension and, thus, stretch.
Rac-1 activation is mediated by guanine exchange factors (GEFs). Overexpression of a dominant-negative version of the GEF ␤PIX (p21-activated kinase-interacting exchange factor) prevented the stretch-induced increase in O 2 ⅐Ϫ formation and endothelial dysfunction. That these effects might also be operative in vivo was suggested by the fact that an increased ILK-1 expression, Rac-1 activation, and O 2 ⅐Ϫ formation was also detected in a hypertensive carotid artery of mice subjected to transverse aortic banding. Thus, this work not only documents the great importance of ILK-1 as part of a stretch-induced signaling cascade in the intact vessel, it also further establishes the link between ILK-1 and Rac-1 via the GEF ␤PIX. What makes this study unique is that the authors rigorously concentrate on the intact vessel, whereas previous studies were performed in cultured cells or even cell lines with the aid of stretch apparatus. A couple of limitations arise from this approach, which should be mentioned to avoid an overinterpretation of the results: the mechanisms that induce ILK-1 translocation are not necessarily identical to those that increase the protein level. Inactive ILK-1, that is, without the interaction with other partners of the IPP (ILK PINCH parvin) complex, however, is rapidly degraded by the proteasome. Thus, ILK-1 protein abundance can be a marker for ILK-1 signaling activity.
Moreover, the approach with dominant-negative proteins potentially blocks downstream target proteins for independent stimuli. Thus, at the current stage, it cannot completely be excluded that a different GEF, like Vav2 or pRex1, mediates Rac-1 activation in response to stretch. Because antibodies are not available for most GEFs to control small interfering RNA experiments, the current approach with dominant-negative proteins is the only feasible technique. So far, maybe with the exception of Rho-GEFs, the proteins that activate small GTPases in the vascular system have gained relatively little attention. However, because small GTPases themselves are so tremendously important for almost all cellular processes, a specified control system is required to render GTPase signaling site and stimulus specific. Indeed, Ͼ80 GEFs have been identified in human cells so far, but research on this topic is still in its infancy because of the high diversity of these proteins and their multifunctionality. 6 Sensing stretch is a complex task for cells. Although integrins are well-established mechanosensors, there are sev-eral aspects in the process that are incompletely understood. 7 In particular, under resting conditions, many integrins are present in the inactive, low-affinity state and are primed by protein kinase C and src kinases before they contribute to mechanotransduction. 8 Interestingly, already at this very early point, a contribution of ROS to cell signaling is possible, because src is known to be easily activated by ROS. A role for protein kinase C in stretch-induced ROS production has been observed previously. 4 Because protein kinase C, however, is one of the proteins directly involved in the activation process of NAPDH oxidases by the phosphorylation of p47phox, integrin priming and NADPH oxidase activation are difficult to dissect.
Integrins are not the only mechanosensors in the vasculature. The search for mechanisms mediating the myogenic response (Bayliss effect) has yielded particularly contrasting observations. The current concept is that stretch induces a depolarization of the smooth muscle cells, with a subsequent opening of voltage-dependent calcium channels. The mechanism of the initial depolarization, which may involve crosstalk between the angiotensin II receptor and TRP channels, epithelial sodium channels, or chloride channels is, however, still under debate. 9 Interestingly, also in larger arteries, calcium is required for stretch-induced ROS formation. 4 Moreover, the myogenic response of small vessels is associated with an increased formation of ROS, which is also the consequence of a Rac-1-dependent activation of the NADPH oxidase. 10 In conclusion, with the present work, Vecchione et al 5 provide additional support for the concept that increased vascular ROS formation is an consequence of hypertension. They suggest that an activation of vascular mechanosensors and the subsequent stimulation of the ILK-1/␤PIX/Rac-1 pathway activate the NADPH oxidase and that O 2 ⅐Ϫ generated by this class of enzymes reduces NO availability. The consequence of this process will be endothelial dysfunction and an increase in vascular stiffness (Figure) .
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Figure.
A potential mechanism of hypertension-induced formation of ROS. Hypertension increases the circumferential wall stress, which results in tension between the extracellular matrix and membrane-bound integrins, which are subsequently activated. This event leads to the recruitment of the ILK-1 to the plasma membrane. There it forms the IPP complex and allows for the binding of scaffolding proteins like paxillin. Via the interaction with this adaptor, ␤PIX is attracted to the complex where it also interacts with Rac-1. The latter is activated by this step and subsequently activates the NADPH oxidase. O 2 ⅐Ϫ formed by this enzyme scavenges NO, which results in endothelial dysfunction and an increase in vascular stiffness.
Brandes
Rac-1 and Hypertension-Induced ROS Formation
Ralf P. Brandes
A New PIXel in the Puzzle: How Increased Vascular Pressure Induces Oxidative Stress

